By Staff
Thursday, April 25, 2024 12:27 AM
PADUA, Italy—
Safilo Group S.p.A. (SFLG.MI) has announced that shareholders have approved the company's 2023 financial statements and the board of directors’ report during their annual meeting yesterday, and viewed consolidated financial statements. In addition, a new board of directors was appointed, and as its first action confirmed that Angelo Trocchia, who has served as chief executive officer since April 2018, would continue in this role. Eugenio Razelli has been named chairman of the board of directors, according to the announcement, and director Jeffrey A. Cole is no longer serving on the board.
By Staff
Tuesday, April 9, 2024 12:18 AM
CLEVELAND—The
Eversight Center for Vision and Eye Banking Research has announced that it has awarded four grants to investigators at Tufts University, Wayne State University and University of Michigan to advance promising eye and vision research.
By Staff
Monday, April 8, 2024 12:27 AM
CORALVILLE, Iowa—
Digital Diagnostics, creator of LumineticsCore, an FDA De Novo-cleared, fully autonomous artificial intelligence system for the diagnosis of diabetic retinopathy, has announced the appointment of health care industry veteran Kurt Blasena as its chief commercial officer.
By Staff
Thursday, April 4, 2024 12:15 AM
WATERTOWN, Mass.—
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company that develops therapeutics to improve the lives of patients with serious retinal diseases, has announced the appointment of leading global ophthalmologists to its scientific advisory board.
By Staff
Monday, March 25, 2024 12:15 AM
PALM BEACH GARDENS, Fla.—
Curative Biotechnology Inc. (OTC: CUBT), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, announced the nomination of Dr. Theresa Heah to its board of directors. Dr. Heah is expected to join its board of directors immediately as an independent director. In addition to other board duties, Dr. Heah will serve on the newly created Clinical Development Committee of the board.
By Staff
Friday, March 22, 2024 12:21 AM
SOUTHFIELD, Mich.—
SEE Eyewear, the 40-unit optical retailer operating stores across the country, has announced Rob McCoy, who brings 35 years of experience in the optical industry across diverse geographies and businesses, joined SEE as chief retail officer in mid-March.
By Staff
Tuesday, March 19, 2024 12:15 AM
DELRAY BEACH, Fla.—
Now Optics, parent company of eyecare retail brand
Stanton Optical, has announced its partnership with Scout Onward, a leading athlete search agency, to recruit talented executive team members from sporting backgrounds.
By Staff
Sunday, March 17, 2024 12:18 AM
WALTHAM, Mass.—
Apellis Pharmaceuticals, Inc. (APLS) has appointed leading retina specialist Philip Ferrone, MD, as chief medical retina advisor. “Phil is globally renowned for his leadership in retina, including as a past president of the
American Society of Retina Specialists (ASRS), so we are delighted to welcome him to the Apellis team,” said Caroline Baumal, MD, chief medical officer, Apellis. “Phil has extensive expertise in retina research and patient care, which will be invaluable as we continue to bring Syfovre to patients with geographic atrophy (GA) and advance our retina pipeline.”
By Staff
Wednesday, March 13, 2024 12:21 AM
SAN RAMON, Calif.—
The Wavefront Congress, a convergence of global experts and thought leaders in optical sciences and wavefront technologies for eyecare, has recognized Arthur Bradley, PhD, research fellow at
CooperVision, as a 2024 Luminary for his outstanding contributions to the optometry field for more than four decades. The honor was awarded to him during the Congress, which drew more than 100 optical scientists, clinicians, surgeons and corporate scientists from around the world to Houston, Texas.
By Staff
Monday, March 11, 2024 12:15 AM
KANSAS CITY, Mo.—
Vital Tears, a leader in the development and delivery of autologous serum tears, has announced the appointment of Joseph Tauber, MD, as its chief medical officer (CMO).
By Staff
Wednesday, March 6, 2024 12:33 AM
SABAE, Japan—Eyewear manufacturer
Charmant Group has announced the appointment of Koji Horikawa to the role of president and CEO. Previously executive managing director, Horikawa was approved as the new president and chief executive officer by the shareholder meeting on February 29, 2024. Horikawa is the son of Kaoru Horikawa, founder of Charmant Group. Horikawa began his career in Charmant’s Japanese domestic division 34 years ago, and played a pivotal role in overseeing Chinese manufacturing divisions and product planning while working in China and Hong Kong.
By Staff
Monday, March 4, 2024 12:18 AM
MANSFIELD, Mass.—
Hilco Vision has announced a key addition in its sales leadership. Stuart Jolly has been named the head of sales, Americas – optical & retail division, effective today.
By Staff
Monday, February 26, 2024 12:21 AM
CALGARY, Alberta—
CSI Dry Eye Software, an emerging artificial intelligence (AI) dry eye software company pioneering AI in dry eye diagnostics and treatment recommendations, announced that it has appointed Trudi Charest as chief sales officer.
By Staff
Friday, February 23, 2024 12:24 AM
BEDFORD, Mass.—
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of therapies for diseases and conditions of the eye, has announced board of directors and leadership updates. Pravin U. Dugel, MD has been named executive chairman, and Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD have been appointed to the ocular management team as chief scientific officer, medical director, and chief strategy officer, respectively.
By Staff
Friday, February 23, 2024 12:15 AM
SAN CARLOS, Calif.—
XP Health, a company dedicated to democratizing vision care with a digital-first vision benefits platform, announced a new partnership with Bell Bank and the addition of new chief marketing officer Cynthia Spitalny to grow its leadership roster.